Praxis Precision Medicines (PRAX) News Today $45.94 -1.33 (-2.81%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$45.98 +0.05 (+0.10%) As of 08/8/2025 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Praxis Precision Medicines Down Today?Toggle Visibility of Why Is Praxis Precision Medicines Down Today?Praxis Precision Medicines, Inc. (NASDAQ:PRAX) shares moved after analysts updated their earnings forecasts for the company’s upcoming quarters and long-term outlook. Positive Sentiment: HC Wainwright raised its Q3 2025 EPS estimate for PRAX to ($3.78) from ($4.28), maintaining a “Buy” rating and a $115 price objective. Research Analysts Issue Forecasts for PRAX Q3 Earnings Negative Sentiment: HC Wainwright trimmed its FY2029 EPS forecast to $21.43 from $22.65, despite keeping its “Buy” rating and $115 target. What is HC Wainwright's Estimate for PRAX FY2029 Earnings? Negative Sentiment: Wedbush reduced its Q3 2025 EPS projection for PRAX to ($3.23) from ($2.87), issuing an “Underperform” rating and setting a $28 price target. Wedbush Issues Negative Estimate for PRAX Earnings Posted 15h agoAI Generated. May Contain Errors. PRAX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period HC Wainwright Issues Optimistic Estimate for PRAX EarningsAugust 9 at 2:37 AM | americanbankingnews.comPraxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of VormatrigineAugust 8 at 10:14 PM | theglobeandmail.comResearch Analysts Issue Forecasts for PRAX Q3 EarningsAugust 8 at 8:25 AM | marketbeat.comWhat is HC Wainwright's Estimate for PRAX FY2029 Earnings?August 7 at 8:12 AM | marketbeat.comWedbush Issues Negative Estimate for PRAX EarningsAugust 7 at 6:46 AM | marketbeat.comWedbush Has Negative Outlook for PRAX Q3 EarningsAugust 7 at 2:07 AM | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAXAugust 6 at 6:40 PM | prnewswire.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Praxis Precision Medicines (PRAX) and Pfizer (PFE)August 6 at 6:32 PM | theglobeandmail.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Down 8.1% - Here's WhyAugust 6 at 5:29 PM | marketbeat.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 6 at 5:13 PM | gurufocus.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 6 at 4:01 PM | globenewswire.comPraxis Precision Medicines (PRAX) Projected to Post Earnings on TuesdayAugust 6 at 9:55 AM | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for Praxis Precision Medicines (NASDAQ:PRAX) StockAugust 6 at 8:09 AM | marketbeat.comPraxis Precision Medicines First Half 2025 Earnings: US$6.60 loss per share (vs US$4.58 loss in 1H 2024)August 5, 2025 | finance.yahoo.comPraxis Precision Medicines to Participate in Upcoming Fireside ChatAugust 5, 2025 | globenewswire.comPraxis Precision Medicines, Inc. Investors: Company Investigated by the Portnoy Law FirmAugust 5, 2025 | globenewswire.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down - Time to Sell?August 5, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Posts Earnings Results, Beats Expectations By $0.09 EPSAugust 5, 2025 | marketbeat.comPraxis Precision Medicines to Participate in Upcoming Fireside ChatAugust 4, 2025 | globenewswire.comPraxis Precision Shares Climb on Seizure Treatment Trial ResultsAugust 4, 2025 | marketwatch.comPraxis Precision Medicines stock soars after positive epilepsy drug resultsAugust 4, 2025 | investing.comPraxis Precision jumps after mid-stage trial data for anti-seizure therapyAugust 4, 2025 | msn.comPraxis' Epilepsy Treatment Shows Promise With Decreased SeizuresAugust 4, 2025 | benzinga.comPraxis Precision Medicines Shares Surge on Promising Epilepsy Drug DataAugust 4, 2025 | msn.comPraxis: Positive 8-Week Radiant Study Data Leads To Other Expected CatalystsAugust 4, 2025 | seekingalpha.comPraxis Precision Medicines, Inc. (PRAX) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comPraxis Precision Medicines, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 4, 2025 | seekingalpha.comPraxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial ResultsAugust 4, 2025 | globenewswire.comTD Asset Management Inc Trims Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)August 4, 2025 | marketbeat.comWhat to Expect from Praxis Precision Medicine's EarningsAugust 2, 2025 | benzinga.comY Intercept Hong Kong Ltd Makes New $237,000 Investment in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)July 31, 2025 | marketbeat.comChardan Capital Reaffirms "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX)July 30, 2025 | marketbeat.comPraxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial ResultsJuly 30, 2025 | finance.yahoo.comPraxis Precision Medicines (NASDAQ:PRAX) Given "Buy" Rating at Chardan CapitalJuly 30, 2025 | americanbankingnews.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 23, 2025 | marketbeat.comPraxis Precision Medicines, Inc.: Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A ...July 19, 2025 | finanznachrichten.dePraxis Precision Gets FDA's Breakthrough Designation for Seizure TreatmentJuly 18, 2025 | marketwatch.comPraxis Precision Medicines (NASDAQ:PRAX) Earns Buy Rating from HC WainwrightJuly 18, 2025 | marketbeat.comPraxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic EncephalopathiesJuly 17, 2025 | globenewswire.comBrokers Offer Predictions for PRAX Q1 EarningsJuly 16, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Up 10.4% on Analyst UpgradeJuly 9, 2025 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Price Target Raised to $115.00 at OppenheimerJuly 8, 2025 | marketbeat.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule ...July 2, 2025 | gurufocus.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 2, 2025 | globenewswire.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Rating of "Moderate Buy" by BrokeragesJune 28, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 51,682 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)June 14, 2025 | marketbeat.comNeedham & Company LLC Reaffirms Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)June 12, 2025 | marketbeat.comBank of America Corp DE Reduces Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)June 12, 2025 | marketbeat.comFormer head trader of Denver-based investing company pleads guilty to insider tradingJune 9, 2025 | finance.yahoo.comPraxis Precision Medicines (NASDAQ:PRAX) Trading Up 7.6% - Here's WhyJune 5, 2025 | marketbeat.com Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address PRAX Media Mentions By Week PRAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRAX News Sentiment▼0.270.38▲Average Medical News Sentiment PRAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRAX Articles This Week▼396▲PRAX Articles Average Week Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cytokinetics News Today Avidity Biosciences News Today Vaxcyte News Today PTC Therapeutics News Today Zai Lab News Today ACADIA Pharmaceuticals News Today Arcellx News Today Akero Therapeutics News Today Viking Therapeutics News Today Metsera News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRAX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
